BRAF and carcinoma: A strong rationale for the triple blockade of BRAF, MEK, and EGFR in BRAF V600E-positive advanced carcinoma of the colon and rectum was established after ref. 39 discovered that EGFR inhibition demonstrated synthetic lethality with BRAF V600E blockade.